Format
Sort by
Items per page

Send to

Choose Destination

Best matches for liver transplant:

Liver Transplant for Cholangiocarcinoma: A Comeback? Schmeding M et al. Exp Clin Transplant. (2015)

Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant. Moray G et al. Exp Clin Transplant. (2015)

Efficacy of cell saver use in living-donor liver transplant. Kırnap M et al. Exp Clin Transplant. (2015)

Search results

Items: 1 to 20 of 103984

1.

Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.

Idriss NK, Sayyed HG, Osama A, Sabry D.

Cell Physiol Biochem. 2018 Aug 16;48(5):2161-2171. doi: 10.1159/000492558. [Epub ahead of print]

PMID:
30114694
2.

Clinical Relevance of a Balance Training Program on Liver Transplant Patients. A Randomized Controlled Trial.

Moya-Nájera D, Moya-Herraiz Á, Gargallo P, Calatayud J, Escrig-Sos J, Colado JC.

Transplantation. 2018 Aug 15. doi: 10.1097/TP.0000000000002415. [Epub ahead of print]

PMID:
30113994
3.

Flare of Autoimmune Hepatitis causing acute on chronic liver failure (ACLF): diagnosis and response to corticosteroid therapy.

Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Tan SS, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (AARC) working party.

Hepatology. 2018 Aug 16. doi: 10.1002/hep.30205. [Epub ahead of print]

PMID:
30113706
4.

Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.

Tomic D, Kemp WW, Roberts SK.

Eur J Gastroenterol Hepatol. 2018 Aug 14. doi: 10.1097/MEG.0000000000001235. [Epub ahead of print]

PMID:
30113367
5.

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis.

Masetti C, Lionetti R, Lupo M, Siciliano M, Giannelli V, Ponziani FR, Teti E, Dell'Unto C, Francioso S, Brega A, Montalbano M, Visco-Comandini U, Taibi C, Galati G, Vespasiani Gentilucci U, Picardi A, Andreoni M, Pompili M, Pellicelli AM, D'Offizi G, Gasbarrini A, De Santis A, Angelico M.

J Viral Hepat. 2018 Aug 16. doi: 10.1111/jvh.12982. [Epub ahead of print]

PMID:
30112854
6.

Donor-specific antibodies in pediatric intestinal and multivisceral transplantation: the role of liver and HLA mismatching.

Talayero P, Ramos Boluda E, Gómez Massa E, Castro Panete MJ, Prieto Bozano G, Calvo Pulido J, Paz-Artal E, Mancebo E.

Liver Transpl. 2018 Aug 16. doi: 10.1002/lt.25323. [Epub ahead of print]

PMID:
30112820
7.

Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.

Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N.

Pharmacoepidemiol Drug Saf. 2018 Aug 16. doi: 10.1002/pds.4640. [Epub ahead of print]

PMID:
30112779
8.

Magnetic compression anastomosis for the complete dehiscence of hepaticojejunostomy in a patient after living-donor liver transplantation.

Kubo M, Wada H, Eguchi H, Gotoh K, Iwagami Y, Yamada D, Akita H, Asaoka T, Noda T, Kobayashi S, Nakamura M, Ono Y, Osuga K, Yamanouchi E, Doki Y, Mori M.

Surg Case Rep. 2018 Aug 15;4(1):95. doi: 10.1186/s40792-018-0504-6.

PMID:
30112678
9.

The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.

Lozanovski VJ, Khajeh E, Fonouni H, Pfeiffenberger J, von Haken R, Brenner T, Mieth M, Schirmacher P, Michalski CW, Weiss KH, Büchler MW, Mehrabi A.

Langenbecks Arch Surg. 2018 Aug 15. doi: 10.1007/s00423-018-1704-z. [Epub ahead of print]

PMID:
30112639
10.

Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.

Bergeat D, Turrini O, Courtin-Tanguy L, Truant S, Darnis B, Delpero JR, Mabrut JY, Regenet N, Sulpice L.

Langenbecks Arch Surg. 2018 Aug 15. doi: 10.1007/s00423-018-1702-1. [Epub ahead of print]

PMID:
30112638
11.

Atypical Neuropsychiatric Presentation in a Patient Expecting Liver Transplantation.

Chamelian L, Pereira A, Grant K, Maurice C.

Case Rep Transplant. 2018 Jul 9;2018:4609631. doi: 10.1155/2018/4609631. eCollection 2018.

PMID:
30112246
12.

Complex bile duct network formation within liver decellularized extracellular matrix hydrogels.

Lewis PL, Su J, Yan M, Meng F, Glaser SS, Alpini GD, Green RM, Sosa-Pineda B, Shah RN.

Sci Rep. 2018 Aug 15;8(1):12220. doi: 10.1038/s41598-018-30433-6.

PMID:
30111800
13.

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial.

Chauhan N, Bukovcan J, Boucher E, Cosgrove D, Edeline J, Hamilton B, Kulik L, Master F, Salem R.

JMIR Res Protoc. 2018 Aug 15;7(8):e11234. doi: 10.2196/11234.

PMID:
30111528
14.

[Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation].

Yu D, Han YH, Hu CY, Zhang B, Zhang HX, Li HJ, Qi KM, Cao J, Li ZY, Yan ZL, Xu KL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1174-1179. doi: 10.7534/j.issn.1009-2137.2018.04.038. Chinese.

PMID:
30111426
15.

[Establishment and Identification of MDS Mouse Model with Irom Overload].

Jin X, Sui SN, Xu P, Xin Y, Cao XL, Wan LQ, Men JX, Lu WY, Cui R, Zhao MF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1129-1136. doi: 10.7534/j.issn.1009-2137.2018.04.031. Chinese.

PMID:
30111419
16.

HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.

van Wenum M, Treskes P, Adam AAA, van der Mark VA, Jongejan A, Moerland PD, van Gulik TM, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R.

Cell Physiol Biochem. 2018 Aug 15;48(5):2189-2204. doi: 10.1159/000492560. [Epub ahead of print]

17.

[Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver].

Schmelzle M, Krenzien F, Schöning W, Pratschke J.

Chirurg. 2018 Aug 14. doi: 10.1007/s00104-018-0690-6. [Epub ahead of print] Review. German.

PMID:
30109374
18.

Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.

Xiao J, Xing F, Liu Y, Lv Y, Wang X, Ling MT, Gao H, Ouyang S, Yang M, Zhu J, Xia Y, So KF, Tipoe GL.

Acta Pharm Sin B. 2018 Jul;8(4):575-586. doi: 10.1016/j.apsb.2017.10.003. Epub 2017 Nov 10.

19.

Recent advances in understanding bile duct remodeling and fibrosis.

Scrushy M, O'Brien A, Glaser S.

F1000Res. 2018 Jul 31;7. pii: F1000 Faculty Rev-1165. doi: 10.12688/f1000research.14578.1. eCollection 2018. Review.

20.

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.

Senzolo M, Riva N, Dentali F, Rodriguez-Castro K, Sartori MT, Bang SM, Martinelli I, Schulman S, Alatri A, Beyer-Westendorf J, Di Minno MND, Ageno W; IRSVT study investigators.

Clin Transl Gastroenterol. 2018 Aug 15;9(8):176. doi: 10.1038/s41424-018-0043-2.

PMID:
30108204

Supplemental Content

Loading ...
Support Center